Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Kenneth Lai

Psychiatry Orlando, FL Medical Doctor

NPI 1376893974 CMS profile 1171127

7208 W Sand Lake Rd Ste 305, Orlando, FL 32819

Open in the dashboard

General payments

$3,286

123 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kenneth Lai of Orlando, FL is reported in the CMS Open Payments database as having received $3,286 across 123 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $164 2
2024 General $1,525 76
2023 General $1,475 44
2022 General $122 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Lai
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Kenneth Lai were reported at $164. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Kenneth Lai Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $122 $153 $50–$590 $149
2023 $1,475 $170 $56–$651 $160
2024 $1,525 $179 $57–$673 $164
2025 $164 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. ITI, Inc. $530 20 payments
  2. AbbVie, Inc. $526 18 payments
  3. Corium, Inc. $415 14 payments
  4. Neurocrine Biosciences, Inc. $366 13 payments
  5. Organogenesis Inc. $249 2 payments
  6. Otsuka America Pharmaceutical, Inc. $247 8 payments
  7. Lundbeck LLC $178 11 payments
  8. Janssen Pharmaceuticals, Inc $155 6 payments
  9. Teva Pharmaceuticals USA, Inc. $132 7 payments
  10. Supernus Pharmaceuticals, Inc. $126 4 payments
  11. Other $363 20 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $3,286 123 payments
Products named General payments · program years 2022–2025
  1. VRAYLAR $526 18 payments
  2. Azstarys $415 14 payments
  3. CAPLYTA Psychiatry $366 18 payments
  4. INGREZZA $366 13 payments
  5. ABILIFY MAINTENA $216 6 payments
  6. REXULTI $178 11 payments
  7. CAPLYTA Psychiatry $164 2 payments
  8. Austedo XR $132 7 payments
  9. Affinity $125 1 payment
  10. Puraply Antimicrobial $124 1 payment
  11. Other $869 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 55 drugs

Part D claims

3,081

Median for Psychiatry: 574

Drug cost

$288,120

Median for Psychiatry: $27,624

Branded share of claims

14.2%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rexulti Brexpiprazole Brand 39 $73,440
Invega Sustenna Paliperidone Palmitate Brand 20 $66,662
Vraylar Cariprazine Hcl Brand 26 $36,713
Caplyta Lumateperone Tosylate Brand 12 $23,153
Aripiprazole Generic 103 $17,803
Lurasidone Hcl Generic 46 $9,957
Rivastigmine Generic 56 $8,164
Tetrabenazine Generic 23 $6,537
Ziprasidone Hcl Generic 60 $4,722
Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine Brand 38 $2,962

The 10 drugs with the highest cost, of 55 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$20,166

Medicare's payments for the services billed

Medicare patients

92

Average age 58

Services billed

368

56 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Depression 62%
Diabetes 52%
Arthritis 38%
COPD 16%
Chronic kidney disease 14%
Ischemic heart disease 13%
Alzheimer's or dementia 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 19 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $316
$316 26 —
INGREZZA
  • Neurocrine Biosciences, Inc. $180
$180 — —
CAPLYTA
  • ITI, Inc. $173
$173 12 —
REXULTI
  • Lundbeck LLC $145
  • Otsuka America Pharmaceutical, Inc. $27
$172 39 —
Azstarys
  • Corium, Inc. $166
$166 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 19 in the dashboard with a free account

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record